Elena Crispino

Orcid: 0000-0001-9289-4926

According to our database1, Elena Crispino authored at least 10 papers between 2022 and 2024.

Collaborative distances:
  • Dijkstra number2 of four.
  • Erdős number3 of four.

Timeline

Legend:

Book 
In proceedings 
Article 
PhD thesis 
Dataset
Other 

Links

On csauthors.net:

Bibliography

2024
Pioneering bioinformatics with agent-based modelling: an innovative protocol to accurately forecast skin or respiratory allergic reactions to chemical sensitizers.
Briefings Bioinform., 2024

ICPR 2024 Competition on Multiple Sclerosis Lesion Segmentation - Methods and Results.
Proceedings of the Pattern Recognition. Competitions - 27th International Conference, 2024

2023
Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza.
BMC Bioinform., December, 2023

Boosting multiple sclerosis lesion segmentation through attention mechanism.
Comput. Biol. Medicine, July, 2023

Enhancing Multiple Sclerosis Lesion Segmentation in Multimodal MRI Scans with Diffusion Models.
Proceedings of the IEEE International Conference on Bioinformatics and Biomedicine, 2023

Genetic Algorithm-Based Prediction of Emerging SARS-CoV-2 Variants: A Computational Biology Perspective.
Proceedings of the IEEE International Conference on Bioinformatics and Biomedicine, 2023

Modeling Cutaneous Leishmaniasis: Insights into M1/M2 Macrophage Dynamics Using the Universal Immune System Simulator.
Proceedings of the IEEE International Conference on Bioinformatics and Biomedicine, 2023

Predictive Modelling of Allergic Responses to Chemical Sensitizers: Distinguishing Skin and Respiratory Reactions.
Proceedings of the IEEE International Conference on Bioinformatics and Biomedicine, 2023

2022
Cutaneous Leishmaniasis: discovering new effective therapies using the Universal Immune System Simulator.
Proceedings of the IEEE International Conference on Bioinformatics and Biomedicine, 2022

Genetic algorithm application for the prediction of potential SARS-CoV-2 new variant of concern.
Proceedings of the IEEE International Conference on Bioinformatics and Biomedicine, 2022


  Loading...